Objective: We examined whether cognitive impairments or depressive symptoms impeded improvement in upper limb function in a clinical repetitive task practice program.
Upon completions of this article, the reader should be able to: 1) Discuss the importance of considering the effects of cognitive impairments and depressive symptoms on clinical repetitive task practice program outcomes. 2) Describe the influences of cognitive impairments and depressive symptoms on upper extremity recovery. 3) Discuss the potential role that phase of neurological recovery (i.e., subacute, chronic) may have had on the incidence of cognitive impairments and depressive symptoms, as well as the trajectory of upper extremity recovery. 3, 4 ; therefore, it is important to empirically examine whether cognitive impairments and depressive symptoms influence treatment response attributed to repetitive task practice programs.
Level:
Repetitive task practice studies usually exclude individuals with severe cognitive impairments (typically defined by Mini-Mental State Examination score G24), 2 and no studies have reported whether cognitive impairments influenced treatment response. One study has examined whether depressive symptoms influenced treatment response, reporting that depressive symptoms did not seem to limit treatment response to a progressive exercise program focused on strength, balance, endurance, and upper limb function. 5 Our pilot study examined whether cognitive impairments and depressive symptoms influenced improvement in upper limb function in an outpatient clinical program using a standardized repetitive task practice protocol. We predicted that clients with cognitive impairments and clients with depressive symptoms would demonstrate less improvement in upper limb function in time compared with clients without these impairments or symptoms.
METHODS
Procedures were approved by the university institutional review board. Participants were recruited from clients referred to a protocol-driven repetitive task practice program at an outpatient occupational therapy clinic affiliated with the academic health center (n = 20). Inclusion criteria were (1) unilateral hemiparesis caused by stroke (diagnosed at the time of onset using World Health Organization criteria), 6 (2) mild to moderate upper limb impairment (at least 15 degrees active elbow flexion, 15 degrees active wrist extension, and 10 degrees active distal interphalangeal flexion), and (3) limited upper limb use (Motor Activity Log Q3).
7 Exclusion criteria were (1) subdural or subarachnoid hemorrhage, (2) stroke location in brainstem or cerebellum, (3) inability to understand and follow one-step directions in four of five attempts, (4) learning disability or dementia, and (5) progressive neurologic condition (i.e., multiple sclerosis).
We characterized baseline cognitive function using the Repeatable Battery of Neuropsychological Status. 8 The Repeatable Battery of NeuropsychologicalStatus is a valid and reliable battery that assesses cognitive function in five domains (immediate memory, attention, visual spatial function, language, and delayed memory) and yields an ageadjusted total index score (mean, 100; SD, 15). We defined the presence of cognitive impairments as a total index score greater than 1 standard deviation below the mean or a score less than 85. We measured baseline depressive symptom burden using the Hamilton Rating Scale for Depression (HamD). 9 The HamD is a standardized interviewbased assessment examining the frequency and intensity of 17 depressive symptoms, yielding a total score ranging from 0 to 52. We defined the presence of a clinically meaningful level of depressive symptoms as a total score greater than 7.
10
Upper limb function was measured at baseline, after treatment (week 4), and at follow-up (week 24) using the Action Research Arm Test.
11
The Action Research Arm Test is a standardized performance assessment of grasp, grip, pinch, and gross motor tasks. These tasks address both impairment of voluntary movement functions and disability of fine hand use, as defined using the International Classification of Functioning, Disability, and Health.
12 Nineteen items are rated on a scale from 0 (no movement possible) to 4 (movement performed normally), yielding a total score ranging from 0 to 57. All assessments were administered by trained raters supervised by licensed occupational therapy, neuropsychology, and psychiatry personnel. Upon completion of baseline testing, participants were engaged in a protocol-driven repetitive task practice program that involved both clinic and home practice components. The clinic component provided therapist-supervised repetitive task practice activities with a duration of 60 mins per visit, three visits per week, for 4 wks. The home practice component required that participants complete 60 mins of practice per day, 7 days per week for 4 wks. The participants documented home-based practice time using structured diaries. In both clinicand home-based programs, repetitive task practice activities were selected in collaboration with each participant based on baseline motor abilities and interests and focused on grip, grasp, manipulation, and reaching activities using contextually relevant objects available in the participants' homes (full protocol and compendium of activities available from the corresponding author).
We examined differences in characteristics between individuals based on cognitive function and depressive symptom burden using W 2 and independent t tests. To test the study hypotheses, we conducted two separate mixed-effects model analyses using an unstructured repeated-measure covariance structure to account for the lack of compound symmetry in the residual covariance matrix. In the first analysis, we examined differences in mean total Action Research Arm Test scores between groups (cognitive impairments, no cognitive impairments) and over time (baseline, week 4, week 24), controlling for covariates identified in the descriptive analyses. In the second analysis, we repeated the same procedures but changed the groups (depressive symptoms, no depressive symptoms).
RESULTS
Of the 42 clients referred to the clinic for the repetitive task practice program during the study period, 27 provided written informed consent, and 20 met study criteria. Among the seven ineligible participants, the reasons for exclusion were stroke location in the brainstem (2), absence of limited use of impaired upper limb (2), and co-morbid progressive neurologic conditions (3). Eligible and ineligible participants did not differ with respect to age, sex, time since onset, or stroke hemisphere (data not shown). Table 1 provides the characteristics of eligible participants (n = 20). The mean age of the sample was 60 (T 12) yrs, and 50% were male. Sixty percent sustained stroke in the left hemisphere, and 50% experienced impairment of their dominant upper limb. All participants completed the intervention program Upper Limb Recovery After Stroke and baseline and week 4 assessments. Furthermore, all participants completed a minimum of 45 mins of home-based practice 7 days a week during the 4-wk program, and there were no differences in average minutes of home-based practice between groups. We added the week 24 assessment after the first five participants completed the study, so only 15 participants completed the week 24 assessment.
Comparing participants with and without cognitive impairments, only baseline cognitive function scores were significantly different between groups (t 17 = 4.34, P G 0.001). However, we added time since stroke as a covariate in the analyses given the clinically meaningful difference between groups. Participants with and without cognitive impairments improved significantly over time (F 1,17 = 84.48, P G 0.001; Fig. 1 ), regardless of cognitive status (t 31 = 1.42, P = 0.16) or time since stroke (t 17 = 0.07, P = 0.95).
Comparing participants with and without depressive symptoms, only baseline depressive symptom levels were significantly different between groups (t 18 = 6.63, P G 0.001). Once more, we added time since stroke as a covariate in the analyses. Participants with and without depressive symptoms improved significantly over time (F 1,18 = 86.29, P G 0.001), but participants with depressive symptoms demonstrated greater improvement than did participants with no depressive symptoms (t 31 = 3.19, P = 0.003; Fig. 2 ). Time since stroke did not influence rate of recovery in either group (t 17 = 0.06, P = 0.95).
DISCUSSION
Preliminary findings suggest that neither cognitive impairments nor depressive symptoms impede treatment response and that individuals with these deficits are still likely to benefit from repetitive task practice programs; that is, despite cognitive impairments and depressive symptoms, individuals demonstrated improvements in the ability to use the affected upper limb during grasp, grip, pinch, and gross motor tasks, and these improvements were maintained at the week 24 follow-up assessment.
Participants with cognitive impairments and depressive symptoms in this sample were in the subacute phase of neurologic recovery (i.e., less than 1 yr). It is possible that cognitive impairments and depressive symptoms resolve over time and therefore are not as likely to be detected among individuals in the chronic phase of recovery. Approximately 30% to 50% of individuals demonstrate cognitive impairments within the first 3 mos after stroke, with as much as 50% of these individuals demonstrating improvement in the first year. 13 Furthermore, the peak incidence of depressive symptoms occurs 3 to 6 mos after stroke and then tapers off by 1 yr. 4, 14 It may also be true that individuals who have persistent cognitive impairments and depressive symptoms are less likely to seek intervention through outpatient clinical programs. Nonetheless, the findings do raise the question as to whether clients in the subacute phase are more likely to show greater improvement in upper limb function than clients in the chronic phase of recovery with the same severity of cognitive impairments and depressive symptoms. Previous studies have reported accelerated trajectories of upper limb recovery in the acute and subacute phases of recovery compared with the chronic phase of recovery. 15 The pilot study was not designed to address this question. Although time since stroke was not a significant factor in either analysis, we suggest that future studies stratify participants based on chronicity.
Participants with depressive symptoms demonstrated significantly greater improvement in upper limb function over time than did participants with little to no depressive symptoms. This unexpected finding is intriguing but is similar to findings reported elsewhere. 5 In the current study, participants with depressive symptoms were in the subacute phase of recovery and therefore may have had more potential for greater improvement in upper limb function than did participants with little to no depressive symptoms who were in the chronic phase of recovery. However, Lai et al. 5 reported greater improvements in upper limb function among participants with significant depressive symptoms, and all participants (whether experiencing significant or insignificant levels or depressive symptoms) were in the subacute phase of recovery. 5 It may also be that between our exclusion of potential participants with major depressive disorder (HamD Q16), and our cutoff score for depressive symptoms (HamD 97), we isolated participants with minor depression or with an adjustment disorder with depressive symptoms. Both of these conditions are less severe than major depressive disorder and are typically not treated with medications. A structured repetitive task practice program that involves activation and socialization may have provided a positive effect on mood that influenced recovery. 16 Nonetheless, given the small sample, we cannot generalize these findings beyond this clinical study. This pilot study was only an initial clinical examination of the influences of cognitive impairments and depressive symptoms on treatment response. Given the small sample, we were limited in exploring the influences of selected domains of cognitive impairments (i.e., attention, visuospatial function) or selected depressive symptoms (i.e., depressed mood, anhedonia). Nonetheless, preliminary findings suggest that clients with global cognitive impairments and depressive symptoms who have mild to moderate upper limb impairment do seem to benefit from repetitive task practice programs and thus should not necessarily be excluded from these clinical programs. The answers to any essay questions must be typed or computer printed on a separate piece of paper and attached to this page. After finishing this exam: 1. Check your answers with the correct answers on page xxx.
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